1. Home
  2. EVGO vs ORGO Comparison

EVGO vs ORGO Comparison

Compare EVGO & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGO

EVgo Inc.

HOLD

Current Price

$1.04

Market Cap

195.6M

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

BUY

Current Price

$1.04

Market Cap

166.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
EVGO
ORGO
Founded
2010
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.6M
166.0M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
EVGO
ORGO
Price
$1.04
$1.04
Analyst Decision
Buy
Hold
Analyst Count
10
2
Target Price
★ $3.34
$2.00
AVG Volume (30 Days)
★ 2.8M
750.4K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
★ 1600.00
EPS
★ N/A
N/A
Revenue
$54,588,000.00
★ $564,169,000.00
Revenue This Year
$6.04
N/A
Revenue Next Year
$28.83
$37.55
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 145.74
17.04
52 Week Low
$1.02
$0.93
52 Week High
$4.29
$7.08

Technical Indicators

Market Signals
Indicator
EVGO
ORGO
Relative Strength Index (RSI) 30.74 26.71
Support Level N/A N/A
Resistance Level $1.53 $2.57
Average True Range (ATR) 0.07 0.08
MACD -0.01 -0.01
Stochastic Oscillator 3.95 23.06

Price Performance

Historical Comparison
EVGO
ORGO

About EVGO EVgo Inc.

EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: